Japan Signs ¥112 Billion Flu Vaccine Deal With GSK And Novartis
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare announced Oct. 6 the signing of new flu vaccine purchasing agreements with GlaxoSmithKline and Novartis